EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

News | Magnetic Resonance Imaging (MRI)

Remote Programming of Cardiac Implantable Devices is Safe for MRI Scan

May 4, 2022 — More than 60 million magnetic resonance imaging (MRI) scans are performed worldwide each year, but imaging ...

May 04, 2022

News | Atrial Fibrillation

First Patients in the U.S. Enrolled in Biosense Webster Clinical Study To Evaluate VARIPULSE Catheter for Atrial Fibrillation

May 2, 2022 – Johnson & Johnson MedTech have announced that Biosense Webster, Inc., a worldwide leader in the science ...

May 02, 2022

Dr. Jeff Healey is seen implanting a subcutaneous defibrillator in a patient at the Electrophysiology Lab. Image credit: Owen Thomas, Hamilton Health Sciences.

News | Implantable Cardioverter Defibrillator (ICD)

Study: New Cardiac Defibrillator Much Safer for Patients

May 2, 2022 – High-risk patients who need defibrillators to prevent cardiac arrest can experience fewer complications ...

May 02, 2022

Sponsored Content

Case Study | Cardiovascular Information Systems (CVIS)

Single-Database Cardiology Platform Drives Efficient Workflow and Improves Data Access

Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in ...

April 01, 2021

Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small vessel ischemic stroke patients who receive short-term or intermittent monitoring (i.e., Holter monitors and 30-day external monitors) may not be optimally managed for recurrent stroke prevention versus those who received continuous monitoring with insertable cardiac monitors.

News | Implantable Cardiac Monitor (ICM)

New Simulation Data From the STROKE AF Study Shows Insertable Cardiac Monitors Detect 4 Times More AF than Intermittent Monitoring

April 29, 2022 – Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small ...

April 29, 2022

Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap.

News | EP Mapping and Imaging Systems

Vektor Medical to Present Positive Results from vMap Clinical Validation Study

April 29, 2022 – Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” ...

April 29, 2022

CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, announced the completion of patient enrollment in the CathVision ECGenius System clinical evaluation study at the University of Vermont Medical Center.

News | EP Lab

CathVision Announces Completion of Patient Enrollment at First U.S. Clinical Trial Evaluating High-Fidelity, Low-Noise EP Recording Technology

April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

April 27, 2022

Sponsored Content

Feature | ECG

A Double-Edged Sword: How Over-the-Counter ECG Devices are Impacting Cardiac Care

Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...

March 11, 2020

The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose aspirin therapy for the primary prevention of cardiovascular disease in adults

News | Stroke

New USPSTF Guidance: Continue to Take Low-Dose Aspirin if you have a History of Heart Attack, AFib, Stroke or Vascular Stenting

April 27, 2022 – The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose asp ...

April 27, 2022

Researchers at the National Cerebral and Cardiovascular Center in Japan found that patients aged ≥75 years with non-valvular atrial fibrillation (NVAF) and previous stroke/transient ischemic attack (TIA) more commonly had subsequent ischemic and hemorrhagic events than those without previous stroke/TIA in the prospective, multicenter, observational All Nippon AF In the Elderly (ANAFIE) Registry.

News | Stroke

Elderly NVAF Patients with Previous Stroke Need to be More Cautious for Stroke Recurrence

April 25, 2022 – Researchers at the National Cerebral and Cardiovascular Center in Japan found that patients aged ≥75 ...

April 25, 2022

News | Wearables

Smartwatch App Found to Accurately Detect Atrial Fibrillation

April 14, 2022 – Atrial fibrillation (AFib) was confirmed in nearly 94% of people who were initially identified to have ...

April 14, 2022

Sponsored Content

Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.

Feature | ECG

Moving Beyond Holter ECG: The Rise in Next Generation Technology

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The newer ECG devices we have now are so much less cumbersome. It’s like wearing a Band-Aid versus carrying a bulky device,” said the Greenwood, Mississippi internist. “My patients prefer the more comfortable, wire-free form factor, and the quality is as good as, or better, than the Holter,” continued Boler. “Plus, my patient compliance has increased. With the Holter, the leads sometimes come off. The patient may think the device isn’t working, so they take it off and we have to restart the process.”

February 19, 2020

News | ECG

Biotricity to Launch Commercial Sales of Cardiac Monitoring Device Biotres

April 12, 2022 – Biotricity, a medical diagnostic and consumer healthcare technology company, will officially launch the ...

April 12, 2022

News | EP Lab

Late-breaking Data at ACC.22 with Over 1 Million Patients Demonstrates a Major Gap in Guideline Adherence Resulting in Higher Mortality for Patients with Infected CIEDs

Royal Philips, a global leader in health technology, announced late-breaking results of a large-scale, real-world ...

April 12, 2022

News | Atrial Fibrillation

Zio by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF

April 12, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement ...

April 12, 2022

Sponsored Content

Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.

Feature | Sudden Cardiac Arrest

As Interpretation Criteria Evolve, False Positive Athlete ECG Screening Rates Can Decrease

Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent worldwide. Most professional athletes in the United States are required to take part in comprehensive cardiovascular screening programs to identify often-asymptomatic congenital or inherited heart disorders, and other cardiac risk factors. There remains a debate however, whether to mandate ECGs as part of pre-participation screening programs for student athletes at the collegiate and high school levels or even at younger ages.

October 16, 2018